182 related articles for article (PubMed ID: 1588938)
1. Role of oxidized human plasma low density lipoproteins in atherosclerosis: effects on smooth muscle cell proliferation.
Chatterjee S
Mol Cell Biochem; 1992 Apr; 111(1-2):143-7. PubMed ID: 1588938
[TBL] [Abstract][Full Text] [Related]
2. Oxidized low density lipoprotein stimulates aortic smooth muscle cell proliferation.
Chatterjee S; Ghosh N
Glycobiology; 1996 Apr; 6(3):303-11. PubMed ID: 8724138
[TBL] [Abstract][Full Text] [Related]
3. Oxidized low density lipoproteins stimulate galactosyltransferase activity, ras activation, p44 mitogen activated protein kinase and c-fos expression in aortic smooth muscle cells.
Chatterjee S; Bhunia AK; Snowden A; Han H
Glycobiology; 1997 Jul; 7(5):703-10. PubMed ID: 9254052
[TBL] [Abstract][Full Text] [Related]
4. Oxidized low density lipoproteins and lactosylceramide both stimulate the expression of proliferating cell nuclear antigen and the proliferation of aortic smooth muscle cells.
Chatterjee S
Indian J Biochem Biophys; 1997; 34(1-2):56-60. PubMed ID: 9343929
[TBL] [Abstract][Full Text] [Related]
5. Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification.
Tertov VV; Kaplun VV; Sobenin IA; Orekhov AN
Atherosclerosis; 1998 May; 138(1):183-95. PubMed ID: 9678784
[TBL] [Abstract][Full Text] [Related]
6. Effect of crocin on experimental atherosclerosis in quails and its mechanisms.
He SY; Qian ZY; Tang FT; Wen N; Xu GL; Sheng L
Life Sci; 2005 Jul; 77(8):907-21. PubMed ID: 15964309
[TBL] [Abstract][Full Text] [Related]
7. The effects of low density lipoproteins modified by incubation with chondroitin 6-sulfate on human aortic smooth muscle cells.
Tîrziu D; Jinga VV; Serban G; Simionescu M
Atherosclerosis; 1999 Nov; 147(1):155-66. PubMed ID: 10525137
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidylcholine is a major contributor to the synergistic effect of mildly oxidized low-density lipoprotein with endothelin-1 on vascular smooth muscle cell proliferation.
Watanabe T; Pakala R; Katagiri T; Benedict CR
J Cardiovasc Pharmacol; 2002 Mar; 39(3):449-59. PubMed ID: 11862125
[TBL] [Abstract][Full Text] [Related]
9. In vivo oxidized low density lipoprotein: degree of lipoprotein oxidation does not correlate with its atherogenic properties.
Tertov VV; Kaplun VV; Orekhov AN
Mol Cell Biochem; 1998 Jun; 183(1-2):141-6. PubMed ID: 9655188
[TBL] [Abstract][Full Text] [Related]
10. Proliferative effects of oxidized low-density lipoprotein on vascular smooth muscle cells: role of dietary habits.
Lähteenmäki TA; Korpela R; Tikkanen MJ; Karjala K; Laakso J; Solatunturi E; Vapaatalo H
Life Sci; 1998; 63(12):995-1003. PubMed ID: 9749822
[TBL] [Abstract][Full Text] [Related]
11. Carvedilol, a new vasodilating beta-adrenoceptor blocker, inhibits oxidation of low-density lipoproteins by vascular smooth muscle cells and prevents leukocyte adhesion to smooth muscle cells.
Yue TL; Wang X; Gu JL; Ruffolo RR; Feuerstein GZ
J Pharmacol Exp Ther; 1995 Jun; 273(3):1442-9. PubMed ID: 7791119
[TBL] [Abstract][Full Text] [Related]
12. Influence of oxidized low density lipoprotein on the proliferation of human artery smooth muscle cells in vitro.
Qiao C; Zhang K; Xia J
J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):20-3. PubMed ID: 17393100
[TBL] [Abstract][Full Text] [Related]
13. Carbamylated low-density lipoprotein induces death of endothelial cells: a link to atherosclerosis in patients with kidney disease.
Ok E; Basnakian AG; Apostolov EO; Barri YM; Shah SV
Kidney Int; 2005 Jul; 68(1):173-8. PubMed ID: 15954906
[TBL] [Abstract][Full Text] [Related]
14. Effect of lipoproteins on cultured human mesangial cells.
Nishida Y; Yorioka N; Oda H; Yamakido M
Am J Kidney Dis; 1997 Jun; 29(6):919-30. PubMed ID: 9186079
[TBL] [Abstract][Full Text] [Related]
15. Oxidized low density lipoprotein stimulates collagen production in cultured arterial smooth muscle cells.
Jimi S; Saku K; Uesugi N; Sakata N; Takebayashi S
Atherosclerosis; 1995 Jul; 116(1):15-26. PubMed ID: 7488330
[TBL] [Abstract][Full Text] [Related]
16. Oxidized low density lipoproteins stimulate phosphoinositide turnover in cultured vascular smooth muscle cells.
Resink TJ; Tkachuk VA; Bernhardt J; Bühler FR
Arterioscler Thromb; 1992 Mar; 12(3):278-85. PubMed ID: 1312338
[TBL] [Abstract][Full Text] [Related]
17. Oxidized low-density lipoproteins in atherogenesis: possible mechanisms of action.
Weisser B; Locher R; Mengden T; Sachinidis A; Vetter W
J Cardiovasc Pharmacol; 1992; 19 Suppl 2():S4-7. PubMed ID: 1377304
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of low density lipoproteins on insulin-like growth factor-1 (IGF-1) and IGF-1 receptor expression in vascular smooth muscle cells.
Scheidegger KJ; James RW; Delafontaine P
J Biol Chem; 2000 Sep; 275(35):26864-9. PubMed ID: 10862615
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of cultured smooth muscle cell proliferation and injury, utilizing glycated low density lipoproteins with slight oxidation, auto-oxidation, or extensive oxidation.
Taguchi S; Oinuma T; Yamada T
J Atheroscler Thromb; 2000; 7(3):132-7. PubMed ID: 11480453
[TBL] [Abstract][Full Text] [Related]
20. Effects of oxidized low density lipoprotein on the growth of human artery smooth muscle cells.
Zhao GF; Seng JJ; Zhang H; She MP
Chin Med J (Engl); 2005 Dec; 118(23):1973-8. PubMed ID: 16336833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
